Jack M. Zuckerman

Canadian Journal of Urology, Vol.26, No.4, pp. 9863-9863, 2019

Abstract This article has no abstract. More >

M. Francesca Monn, Brian M. Orr, Matthew J. Mellon

Canadian Journal of Urology, Vol.26, No.4, pp. 9859-9862, 2019

Abstract Introduction: Artificial urinary sphincters (AUS) are used to treat significant urinary incontinence. Flexible cystoscopy at the time of AUS placement provides relevant intraoperative feedback including confirmation that the AUS is functioning, visualization of coaptation, and evaluation for urethral injury. Current guidelines for placement of an AUS do not include flexible cystoscopy. The objective was to evaluate whether flexible cystoscopy at time of AUS placement changed cuff size at the time of surgery.
Materials and methods: A retrospective cohort study was performed to evaluate all patients undergoing AUS placement by a single surgeon between March 2013 and March… More >

Syed Johar Raza, Caleb Miller, Allison May, Facundo Davaro, Sameer Ahmed Siddiqui, Zachary Hamilton

Canadian Journal of Urology, Vol.26, No.4, pp. 9852-9858, 2019

Abstract Introduction: The use of lymph node density (LND) as a predictor of survival outcomes has been studied with urothelial carcinoma of the bladder. Similar results can be postulated to upper tract urothelial carcinoma (UTUC). This study aims to determine the overall survival of patients with lymph node positive UTUC based on LND, utilizing the National Cancer Database (NCDB).
Materials and methods: Data was derived from NCDB Participant User Kidney Dataset using the histology code ‘transitional cell carcinoma’, utilizing pN+ patients from 2004-2015. LND was calculated as number of positive nodes divided by total number of nodes removed.… More >

Come Tholomier^1,2, Felix Couture^1,3, Khaled Ajib¹, Felix Preisser^4,5, Helen Davis Bondarenko¹, Cristina Negrean¹, Pierre Karakiewicz^1,4, Assaad El-Hakim⁶, Kevin C. Zorn¹

Canadian Journal of Urology, Vol.26, No.4, pp. 9843-9851, 2019

Abstract Introduction: Robotic-assisted radical prostatectomy (RARP) has grown to be the predominant global surgical approach to treat localized prostate cancer. However, there is still limited access to robotic technology and little data from Canadian cohorts. Herein, we report on our oncological and functional outcomes after 10 years of surgical experience.
Materials and methods: Prospective data from 1,034 RARP cases performed by two high-volume experienced surgeons at two academic centers were collected from October 2006 to June 2017. Preoperative characteristics, surgical, oncological, and functional outcomes were assessed up to 72 months postoperative.
Results: D’Amico risk distribution was 26.1%, 59.8%, and… More >

Akhil K. Das^*, Seth Teplitsky^*, Alex Uhr, Joon Yau Leong, Victor Kucherov, Patrick J. Shenot

Canadian Journal of Urology, Vol.26, No.4, pp. 9836-9842, 2019

Abstract Introduction: Holmium endoscopic laser enucleation of the prostate (HoLEP) is a well-established alternative to traditional transurethral resection and open prostatectomy for the treatment of benign prostatic hyperplasia (BPH). We investigate the 1470 nm diode laser for enucleation as an alternative to HoLEP. The safety, efficacy, and initial outcomes of diode enucleation of the prostate (DiLEP), when compared to HoLEP, were examined.
Materials and methods: We reviewed records of 50 patients who underwent DiLEP between 2012 and 2015 and matched them with 50 HoLEP patients during the same time period. Objective evaluation of efficacy was determined by comparing… More >

David E. Rapp, Mikel Gray

Canadian Journal of Urology, Vol.26, No.4, pp. 9835-9835, 2019

Abstract This article has no abstract. More >

Naomi N. Vinod¹, Anna S. Nagle², Hameeda A. Naimi¹, Hiren Kolli¹, Derek Sheen¹, Naveen Nandanan¹, Laura R. Carucci³, John E. Speich², Adam P. Klausner^1,4

Canadian Journal of Urology, Vol.26, No.4, pp. 9829-9834, 2019

Abstract Introduction: The aim of this study was to investigate conventional 3D ultrasound and portable BladderScan volume measurements and implement correction factors to ensure accurate volume metrics.
Materials and methods: Healthy participants without urinary urgency were recruited for a prospective hydration study in which three consecutive voids were analyzed for two separate visits. Just before and after voiding, 3D ultrasound and BladderScan volumes were measured. Estimated voided volumes were calculated as the volume immediately prior to void minus any post void residual and were compared to actual voided volumes measured using a graduated container. Percent errors were calculated,… More >

Claus G. Roehrborn¹, Franklin C. Lowe², Marc Gittelman³, Jan M. Wruck⁴, Anna E. Verbeek⁵

Canadian Journal of Urology, Vol.26, No.4, pp. 9821-9828, 2019

Abstract Introduction: Treatment for lower urinary tract symptoms (LUTS) is often delayed, as it is considered a natural progression of aging. We described baseline demographic and clinical characteristics of men currently not using prescription medications for benign prostatic hyperplasia (BPH) but interested in self-directed use of over-the-counter (OTC) tamsulosin and who had participated in OTC tamsulosin–simulated studies.
Materials and methods: Pooled baseline data from four OTC tamsulosin–simulated studies were analyzed for men who were currently not using BPH prescription medication and who believed that OTC tamsulosin was appropriate for use or were interested in purchasing it. Data from… More >

Mazen Alsinnawi¹, Jennifer Cullen^2,3,4, Lauren M. Hurwitz^2,3, Katherine E. Levie^2,3, John F. Burns¹, Inger L. Rosner^2,5, Timothy C. Brand^2,6, Sean Stroup^2,7, Joseph R. Sterbis^2,8, Kevin Rice^2,5, Galen Conti^2,3, Christopher R. Porter^1,2

Canadian Journal of Urology, Vol.26, No.4, pp. 9809-9820, 2019

Abstract Introduction: To assess the impact of primary and secondary therapies for high- and intermediate-risk prostate cancer on health-related quality of life (HRQoL).
Materials and methods: A prospective study was initiated in 2007 at Center for Prostate Disease Research Multicenter National Database sites. Longitudinal patterns in HRQoL from baseline (pre-treatment) to 5 years post-diagnosis were examined for patients with high- and intermediate-risk prostate cancer, treated by radical prostatectomy (RP) or external beam radiation therapy (EBRT). Change in HRQoL was modeled using linear regression models fit with generalized estimating equations. The probability of maintaining HRQoL was compared between patients… More >

Leonard G. Gomella

Canadian Journal of Urology, Vol.26, No.4, pp. 9802-9802, 2019

Abstract This article has no abstract. More >